Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
IbafloxacinPDL I DEC / 13
Ibandronic acid or its saltsPDL I DEC / 13
Ibogaine or its salts or derivatives or analoguesPDL I MAY / 17
Ibrutinib or its saltsPDL I DEC / 14
Ibuprofen or its saltsPDL

For veterinary use.

I DEC / 13
Ibuprofen or its saltsPDL

For human use - except when sold in an oral dosage form that provides 400 mg or less per dosage unit or in a modified-release oral dosage form that provides 600 mg or less per dosage unit.

I AUG / 16
Ibuprofen or its salts. when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes exceeding 18,000 mg) III FEB / 12
Ibuprofen or its salts..

when sold in a modified-release oral dosage form that provides 600 mg or less per dosage unit

III AUG / 16
Ibuprofen or its salts... when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes of up to 18,000 mg) U FEB / 12
Ibutilide or its salts or derivativesPDL I DEC / 13
Icatibant or its saltsPDL

Including but not limited to Icatibant acetate.

I AUG / 14
Icosapent ethylPDL

For veterinary use.

I FEB / 20
Icosapent ethylPDL

For human use: when sold or recommended to reduce the risk of cardiovascular events in statin-treated patients with elevated triglycerides.  

I FEB / 20
Idarubicin or its saltsPDL I DEC / 13
IdarucizumabPDL I AUG / 16
IdebenonePDL I DEC / 13
IdelalisibPDL I MAY / 15
IdoxuridinePDL I DEC / 13
IdursulfasePDL I DEC / 13
IfosfamidePDL I DEC / 13
Imatinib or its saltsPDL I DEC / 13
Imidapril or its saltsPDL I DEC / 13
ImiglucerasePDL I DEC / 13
Imipramine or its saltsPDL I DEC / 13
Imiquimod or its saltsPDL I DEC / 13
Immune globulin products I FEB / 02
Immunogenic substancesPDL

When recommended for sublingual use, including but not limited to: anthoxanthium odoratum L. (sweet vernal grass), betula verrucosa (white birch), dactylis glomerata L. (cocksfoot), lolium perenne L. (rye grass), phleum pratense L. (timothy grass), poa pratense L. (meadow grass).

I JUL / 20
Indacaterol or its salts or derivativesPDL I DEC / 13
Indapamide or its saltsPDL I DEC / 13
Indinavir or its saltsPDL I DEC / 13
IndomethacinPDL I DEC / 13
InfliximabPDL I DEC / 13
Influenza vaccine II DEC / 98
Ingenol mebutate or its derivativesPDL I DEC / 13
Inhaled human insulinPDL I DEC / 13
InosiplexPDL I DEC / 13
Inotersen or its saltsPDL I NOV / 18
Inotuzumab ozogamicinPDL I MAY / 18
Insulin II SEP / 98
InterferonPDL I DEC / 13
Iodinated glycerol II SEP / 98
Iodine and its salts and derivatives except topical preparations or in oral doses of 1 mg or less per day II DEC / 98
Iodochlorhydroxyquin for topical use II SEP / 98
IodochlorohydroxyquinPDL

For veterinary use.

I DEC / 13
IodochlorohydroxyquinPDL

For human use - except in preparations for topical use on the skin.

I DEC / 13
Ipecac and its extracts and derivatives when used as an emetic II OCT / 98
IpilimumabPDL I DEC / 13
Ipratropium or its saltsPDL I DEC / 13
Iproniazid or its saltsPDL I DEC / 13
Irbesartan or its saltsPDL I DEC / 13
Irinotecan or its saltsPDL I DEC / 13
Iron and its salts and derivatives in preparations with more than 30 mg elemental iron per solid dosage unit or 5 mL oral liquid II SEP / 98
Iron derivativesPDL

For veterinary use - including but not limited to ferumoxytol, for all routes of administration but parenteral.

I DEC / 13
Iron derivativesPDL

For human use - including but not limited to ferumoxytol, iron isomaltoside 1000, for parenteral use only.

I DEC / 13
IsatuximabPDL I JUL / 20
Isavuconazole or its saltsPDL I FEB / 19
Isocarboxazid or its saltsPDL I DEC / 13
IsofluranePDL I DEC / 13
IsoniazidPDL I DEC / 13
Isopropamide and its salts I SEP / 98
Isopropyl myristate in concentration of 50%

for use in the treatment of head lice

III JUL / 07
Isoproterenol (Isoprenaline) or its saltsPDL I DEC / 13
Isosorbide and its salts I SEP / 98
Isotretinoin or its saltsPDL I DEC / 13
Isoxsuprine or its saltsPDL I DEC / 13
Isradipine or its saltsPDL I DEC / 13
Itraconazole or its saltsPDL I DEC / 13
Ivabradine or its salts or derivativesPDL I FEB / 17
Ivacaftor or its derivativesPDL I DEC / 13
Ixazomib or its derivativesPDL I NOV / 16
IxekizumabPDL I AUG / 16

71 result(s)


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act